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Abstract  
BACKGROUND AND AIM: Infection with the protozoan parasite Toxoplasma gondii has a 
worldwide distribution. Congenital infection is the most important part of the disease burden due to 
Toxoplasma infection in humans. Early diagnosis of maternal infection helps to prevent severe 
complications of toxoplasmosis. In the present study, three PCR assays (conventional, nested & 
quantitative) were evaluated for diagnosis of recent toxoplasmosis based on detection of 
Toxoplasma B1 gene.  
MATERIAL AND METHODS: The present study was carried out on 150 pregnant females who 
were serologically negative for anti-Toxoplasma IgG and IgM antibodies.  
RESULTS: The results revealed that out of 12 true positive cases (by 2 out of the 3 PCR 
protocols), 8 cases were positive by cPCR, 11 cases were positive by nPCR and 12 cases were 
positive by qPCR. Accurate estimation of genomic Toxoplasma DNA in positive samples was 
achieved by qPCR. In general, PCR assays offer a sensitive alternative of serological methods for 
diagnosis of recent maternal toxoplasmosis. In addition, qPCR decreases the risk of contamination 
of PCR products being a closed tube method and helps in estimation of infection load.  
CONCLUSIONS: We recommend screening of high-risk pregnant women by qPCR for early 
diagnosis of toxoplasmosis and proper management. 
 
 
 
 
 
 
 
Introduction 
Toxoplasmosis caused by Toxoplasma gondii 
is one of the most prevalent parasitic diseases in 
human beings [1]. The majority of acquired 
transmissions to humans are caused either by the 
ingestion of tissue cysts in infected meat or by the 
ingestion of soil, water, or food contaminated with 
sporulated oocysts derived from the environment [2].  
Congenital infection is the most important part 
of the disease burden due to Toxoplasma infection in 
humans. It occurs when pregnant woman primarily 
acquires Toxoplasma infection during pregnancy.  
Toxoplasma tachyzoites colonize placental tissues 
during the dissemination process and from there can 
gain access to the fetal compartment in about 30% of 
cases [3]. 
Toxoplasmic infection during pregnancy may 
lead to severe or even fatal infection of the fetus [4]. 
Early diagnosis of infection is extremely important to 
prevent the severe complications of congenital 
toxoplasmosis [5].  
A practice bulletin from the American College 
of Obstetricians and Gynecologists on perinatal viral 
and parasitic infections recommends toxoplasmosis 
screening only in high-risk persons or those in whom 
routine ultrasound examination shows findings such 
as hydrocephalus, intracranial calcifications, 
microcephaly, fetal growth retardation, ascites, or 
Clinical Science 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
  416                                                                                                                                                                                                                     http://www.mjms.mk/ 
http://www.id-press.eu/mjms 
 
hepatosplenomegaly [6].  
Many serological methods have been 
developed aiming at diagnosis of toxoplasmosis 
including indirect fluorescence antibody tests (IFATs) 
[7] to hemagglutination; enzyme-linked 
immunosorbent assays (ELISAs); capture ELISAs 
allowing the detection of specific isotypes IgM, IgA, or 
IgE; and immunosorbent agglutination assays 
(ISAGAs), also suitable for IgM, IgA, or IgE detection 
[2]. The conventional single serum assay does not 
make a clear distinction between an acute and a 
chronic infection [8]. The prevalence of high 
Toxoplama IgG antibody titers among normal 
individuals in most populations and the persistence of 
specific IgM antibodies in some persons for long 
periods cause another problem in estimating the 
timing of infection [9, 10]. 
An alternative method of identifying T. gondii 
by mouse inoculation or tissue culture of the clinical 
specimen may confirm the infection by parasites. 
However, this method usually requires several days to 
obtain results and is labor-intensive [11]. Thus, a more 
efficient method is needed to provide rapid and 
quantitative results for the diagnosis of recent T. 
gondii infection during pregnancy. PCR-based 
techniques have been developed for the detection of 
parasite DNA [12, 13] in blood samples [14] and 
amniotic fluid [4]. 
Several gene targets have been used over 
the years, with various performances in relation to the 
use of repeated or single target genes and the means 
of revealing amplification products [15, 16]. The recent 
advent of a real-time quantitative PCR (qPCR) 
technique is a recently introduced technique with 
promising value in many applications including 
pathogen detection in addition to accurate 
quantization [17, 18]. 
These techniques make use of the most 
conserved gene sequences among different strains of 
T. gondii [19], including the B1 gene repetitive 
sequence, the P30 (SAG1) gene, and ribosomal DNA. 
The use of the B1 gene for T. gondii detection 
originated with Burg et al. in 1989 that combined PCR 
amplification with Southern blotting to detect a specific 
B1 gene product [20]. 
The aim of the present study was to diagnose 
Toxoplasma infection in non-immune pregnant 
females and compare the technical performances of 
three PCR assays (conventional PCR, nested PCR 
and real time PCR) for the molecular diagnosis of 
toxoplasmosis using Toxoplasma B1 gene (35 fold 
repeats) as target DNA. 
 
Materials and Methods 
This comparative observational cross-
sectional study was conducted at the Department of 
Obstetrics and Gynecology, Kasr El-Aini Hospital, 
Faculty of Medicine, Cairo University between 
November 2011 and October 2013.  
The Research Ethics Committee approved 
the study protocol. The study population was recruited 
from women who booked within one week of their last 
menstrual period attending the antenatal care clinic for 
work-up. The study included 150 pregnant women 
non-immune to toxoplasmosis (pregnant women with 
positive tests for T. gondii antibody, together with 
those positive or equivocal for T. gondii IgM, were 
excluded from the present study. Informed consents 
were obtained from all candidates. 
All cases were subjected to detailed history 
taking and complete clinical examination, obstetric 
ultrasound and blood sampling for serological and 
molecular assays. 
 
Obstetrics ultrasound  
All participants had an ultrasound scans 
between 6 and 11 weeks to confirm their gestational 
ages, also those proved to be toxoplasmosis positive 
by PCR had detailed anatomical scans every 4 weeks 
starting from their 20
th
 week of gestation  to detect any 
structural anomalies suggestive of congenital 
toxoplasmosis i.e. ventriculomegaly, intracranial 
calcifications, microphthalmia, microcephaly, non-
immune hydrops, ascites, pleural effusion, pericardial 
effusion, hepatosplenomegaly and/or placentomegaly.  
All scans were done by one operator using 
sonographic imaging system Toshiba (console model 
SSA-340A, Toshiba Medical Systems, Tokyo, Japan) 
equipped with 3.75 MHz Convex transducer.  
 
Serological assay  
Collected blood samples were divided in two 
portions. The first portion was added to EDTA tube to 
extract DNA. Sera were separated from the remaining 
part of blood samples and stored frozen at −20°C. 
Sera were tested for anti- Toxoplasma IgM & IgG 
antibodies using a commercial ELISA Kit (Cal biotech 
Inc., CA). The assay was carried out according to the 
manufacturer's instructions and positive cases were 
excluded from the study. 
 
Molecular methods for detection of 
Toxoplasma gondii DNA 
DNA extraction and the three PCR assays 
(conventional PCR, nested PCR and quantitative real 
time PCR) were performed in the present study in the 
Department of Clinical Pathology, Faculty of Medicine, 
Cairo University 
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DNA extraction 
To minimize contamination DNA extraction 
from blood samples was performed on MagnaPure 
Compact Instrument for fully automated nucleic acid 
extraction (Roche Diagnostics GmbH) applying 
Magnetic beads technology. Final pellets were 
suspended in 30
 
µL of TE buffer and stored
 
at –70°C 
until used. 
The reaction conditions of both conventional 
and nested PCR assays were independently and 
thoroughly optimized in the presence of human DNA 
as described by El  Awady et al 2000. 
 
Conventional PCR (cPCR) for detection of 
T.gondii B1 gene  
Conventional PCR method used a forward 
primer (5´-CCG TTG GTT CCG CCT CCT TC-3´) from 
bases 171 to 190 and a reverse primer (5´-GCA AAA 
CAG CGG CAG CGT CT-3´) from bases 602 to 583.  
The optimized conditions for cPCR were the 
following: 0.8ul of each primer (50 pmol/ul), 20 mmol/L 
dNTPs and 1.25 U recombinant taq DNA polymerase 
in 1 × PCR reaction buffer (50 mmol/L KCl and 10 
mmol/L tris-HCl, 1.5 mmol/L Mg2Cl, 0.1% triton × 100) 
[DynAzyme
TM
] for a total reaction volume of 50ul 
including 5ul of sample DNA. The reaction mixtures 
were cycled in Q cycler Quanta Biotech thermal cycler 
by using the following conditions: 94 °C for 2 min, 
followed by 30 cycles of 94°C for 1 min, 57 °C for 2 
min and 72 °C for 3 min.  
 
Nested PCR (nPCR) for detection of T.gondii 
B1 gene  
The nested PCR reaction was performed 
using 5 µl of the first PCR reaction product under 
identical conditions in a reaction mixture identical in 
composition to that of cPCR except that an inner pair 
of primers were added as follows; a forward primer 
(5´-CCG CCT CCT TCG TCC GTC GT-3´) from bases 
180 to 196 and a reverse primer (5´-GTG GGG GCG 
GAC CTC TCT TG-3´) from bases 392 to 372. Inner 
primers were added at final concentration of 50 pmol 
each to a reaction mixture containing 20 mmol/L 
dNTPs, 1.25 U recombinant taq DNA polymerase in 1 
× PCR reaction buffer. Amplification was done by the 
following conditions: 94°C for 2 min, followed by 35 
cycles of 94 °C for 1 min, 58 °C for 1 min and 72°C for 
1 min. The run was terminated with a final extension 
at 72°C for 10 minutes. For each sample, one internal 
positive control tube was included for detection of 
PCR inhibition. It consisted of purified parasite DNA 
equivalent to 0.8 Toxoplasma genome added to 5 ul 
of sample DNA. Two negative control tubes containing 
5 ul of H2O instead of DNA were included in each test 
to detect contaminations 
The reaction products were visualized using 
0.5% ethidium bromide under UV light after 
electrophoresis in a 3% agarose gel in 1 × tris-borate-
EDTA buffer. The expected fragments sizes were 
432bp for cPCR and 213bp for nPCR 
The semi-quantitative/qualitative assay was 
used in this study for the estimation of the 
concentration and quality of DNA in a specimen. The 
concentration of a sample was determined by 
comparing the intensity of the fluorescence of the 
sample to that of the calibration standards (DNA 
marker) using a gel documentation system which is an  
U.V safe cabinet connected to computer with the 
specific soft ware that calculates automatically all 
DNA parameters according to the standard reference. 
The image analyzer system permits complete analysis 
starting from lane creation and band detection with the 
corresponding molecular weight to the semi 
quantitative analysis by nanogram 
 
Quantitative real time PCR (qPCR) for 
detection of Toxoplasma B1 gene: 
Quantitative real time PCR was performed 
with the LightCycler
®
 fastStart DNA Master SYBR 
Green dye, using the LightCycler
®
 1.x/ 2.0/ 480 
instrument and according to the instruction manual of 
Roche Diagnostic (Roche Diagnostics, Hoffmann-La 
Roche Ltd, USA). Primers from bases (5´-CCG TTG 
GTT CCG CCT CCT TC-3´) and (5´-GCA AAA CAG 
CGG CAG CGT CT-3´) were used to amplify 
Toxoplasma B1 gene of 35-fold repeats. The resulting 
PCR fragment of T. gondii was analyzed using the 
LightCycler® Red 640 (detected in channel 640). The 
supplied standard row was used to determine the 
linear range of the reaction and to estimate the 
quantity of the target sequence in unknown samples.  
Soft ware data analysis version 3.5.3 was applied as 
described in the LightCycler
® 
instrument operator's 
manual. The reaction mixture (20 µl; Master SYBR 
Green kit; Roche Diagnostic) contained 0.5 µM of 
each primer, 5 mM MgCl2 and 5 µl
 
templete DNA. All 
capillaries were sealed, centrifuged at 500 g for 5s, 
and then amplified in a LightCycler instrument. 
Amplification was performed for 50 cycles of 95 °C for 
5 s,
 
61 °C for 10 s and 72 °C for 15 s, with
 
an overall 
ramp rate of 20 °C s. A single ﬂuorescence reading for 
each sample was taken at the extension step. 
Quantitative results were expressed by determination 
of the detection threshold or the crossing point (CT), 
which marked the cycle when the ﬂuorescence of the 
given sample signiﬁcantly exceeded the baseline 
signal. They were expressed as a fractional cycle 
number. Then, the crossing points (CTs) were plotted 
against the known parasite concentration to obtain a 
standard curve. The parasite count for a given sample 
was calculated by extrapolation from this standard 
curve. Positive sample speciﬁcity was confirmed by 
determining the melting curve with  different values of 
melting temperatures (Tm) (95 °C, 4.40 °C/s ramp 
rate; 40°C, 2.20 °C/s ramp rate; 65°C, 4.40°C/s ramp 
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rate, 95°C, 0.02°C/s ramp rate continuous 
measurement).  
 
Results  
The present study was carried out on 150 
pregnant females. A mid-trimester ultra-sound 
examination revealed no congenital anomalies 
suggestive of congenital toxoplasmosis. Sera 
collected from all cases were negative for anti 
Toxoplasma IgM & IgG. Serum samples were 
examined by cPCR & nPCR and qPCR aiming at 
detection of Toxoplasma B1 gene. A blood sample 
was considered positive for Toxoplasma if DNA was 
expressed from the sample by two of the three 
molecular assays performed. Samples were reported 
positive for Toxoplasma when the amplified fragments 
of PCR assays separated by gel electrophoresis were 
of the expected length (432 bp for cPCR and 213 bp 
for nPCR) as shown in Figure 1. Out of the 150 cases 
included in the present study, Toxoplasma B1 gene 
was expressed in 8 cases by cPCR and in 12 cases in 
nPCR as shown in Table 1. Regarding specificity of 
cPCR & nPCR assays, no contamination of the PCR 
was observed during the course of the study, as 
inferred from the consistent negativity of negative 
controls. 
 
 
Figure 1: DNA fragments resulting from cPCR (a) and nPCR (b) fractionated on agarose gel followed by visualization with ethidium bromide 
staining. 
 
Figure 1 DNA fragments resulting from cPCR 
(a) and nPCR (b) fractionated on agarose   gel 
followed by visualization with ethidium bromide 
staining. 
Table 1: Positive serum samples for Toxoplasma B1 gene by 
cPCR, nPCR & qPCR assays. 
qPCR nPCR cPCR 
Sample 
number 
+ve +ve (1.5X10
1
) +ve 1 
+ve +ve (1.5X10) -ve 2 
+ve +ve (1.5X10
2
) +ve 3 
+ve -ve +ve 4 
+ve +ve (1.5X10
2
) -ve 5 
+ve +ve (1.5X10
2
) +ve 6 
+ve +ve (1.5X10) -ve 7 
-ve +ve (1.5X10
1
) -ve 8 
+ve +ve (1.5X10
2
) +ve 9 
+ve +ve (1.5X10
1
) +ve 10 
+ve +ve (1.5X10) -ve 11 
+ve +ve (1.5X10
3
) +ve 12 
+ve +ve (1.5X10
2
) +ve 13 
12 12 8 Total 
 
Out of the 150 cases included in the present 
study, 12 cases were positive for Toxoplasma B1 
gene by qPCR that revealed different concentrations 
and variable CT (Table 2).  
The relative quantity of Toxoplasma DNA in 
each blood sample was determined using the 
standard curve provided from Roche Diagnostics.  
Quantitative PCR performed in this study 
showed high specificity as demonstrated by the 
melting curves applied on the positive samples. 
In the present work, a blood sample was 
considered positive for Toxoplasma if DNA was 
expressed from the sample by two of the three 
molecular assays performed. As shown in table (2), a 
total of 12 true positive cases of toxoplasmosis were 
detected in the present study being positive by 2 PCR 
assay. Out of these 12 cases, 8 positive cases were 
detected by cPCR, 11 positive cases were detected 
by nPCR while qPCR detected 12 positive cases. 
Accordingly, the sensitivities of cPCR, nPCR and 
qPCR in detection of Toxoplasma DNA were 67%, 
92% and 100% respectively. 
 
Table 2: The CTs and the corresponding Toxoplasma quantity 
in positive samples by qPCR. 
qPCR CT Sample number 
9.66E
3
 31.91 1 
3.95E
7
 22.13 2 
1.69E
3
 32.87 3 
1.28E
7
 23.48 4 
1.08E
6
 26.44 5 
3.63E
6
 24.99 6 
5.15E
8
 19.06 7 
1.83E
4
 30.20 8 
1.62E
3
 32.94 9 
1.70E
1
 38.68 10 
2.10E
6
 25.65 11 
9.30E
4
 29.43 12 
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As shown in Table 1, one sample was positive 
only by nPCR but was negative by cPCR & qPCR. 
Similarly, another sample was positive only by qPCR 
and negative by cPCR & nPCR. Both cases were 
considered negative for Toxoplasma. 
 
Discussion  
The protozoan Toxoplasma gondii is one of 
the most common infectious pathogenic parasites and 
can cause severe medical complications in infants [5]. 
Congenital infection results from primary maternal 
infection acquired during gestation. The incidence of 
vertical transmission and the severity of fetal damage 
depend on the stage of pregnancy when maternal 
infection occurs [21]. Diagnosis of toxoplasmosis is 
usually performed by serological methods based on 
demonstration of a significant increase in specific IgG 
antibody levels and/or the presence of specific IgM 
and IgA antibodies [10]. 
In the present study, all cases were 
serologically negative for Toxoplasma, yet they were 
diagnosed positive by the assessed molecular assays. 
This may be due to the fact that serological tests may 
fail to detect specific anti-Toxoplasma IgG or IgM 
during the active phase of T. gondii infection, because 
these antibodies may not be produced until after 
several weeks of parasitemia [22]. 
The detection of Toxoplasma nucleic acids by 
molecular techniques as polymerase chain reaction 
(PCR) proved to be a good alternative for serological 
tests [23].  In blood, the parasite is found during the 
phase of parasitemia early in the acute phase of 
infection, and also in reactivated disseminated cases 
[15]. After infection, Toxoplasma gondii DNA appear 
earlier than the immunological response (24). 
In the present study, three PCR assays were 
evaluated (cPCR, nPCR & qPCR) for detection of 
Toxoplasma B1 gene in blood samples. For prenatal 
diagnosis, Chabbert et al. 2004 validated the choice of 
B1 gene-based PCR assays as these assays 
appeared clearly more sensitive than assays targeting 
the single-copy P30 gene [25]. The sensitivity of PCR 
for purified Toxoplasma gondii DNA has been found to 
be very high because B1 gene contains 30-35 copies 
of repetitive sequences in every trophozoite [20]. 
In our study, cPCR detected eight cases; 
nPCR detected 11 cases while qPCR detected 12 
cases of toxoplasmosis. Therefore, qPCR was more 
sensitive than nPCR and cPCR in detection of 
Toxoplasma B1 gene. Similarly, Lin et al. 2000 
demonstrated that real-time PCR of the B1 gene is 
sensitive and highly reproducible 
On the other hand, real time PCR did not 
appear to be more sensitive than cPCR as stated by 
other researchers [17, 26]. The difference in results 
may be explained by lack of standardization of PCR 
assays and diversity in the protocols used regarding 
DNA extraction methods, DNA targets for 
amplification or the primers used [27]. 
In the present study, we were able to estimate 
the amount of Toxoplasma DNA in each positive 
sample by qPCR. Although both nested and real-time 
PCR are useful in the analysis of clinical specimens 
and may achieve similar levels of assay sensitivity, 
the major advantages of real-time PCR are its ability 
to accurately quantify the infection load of a clinical 
specimen [5]. Quantification of infection load has been 
used to assess disease severity and treatment 
outcome [28]. 
The negativity of other samples included in 
our study did not exclude the possibility of acute 
infection because the exact kinetics of parasitemia in 
infected people is not well known [29]. The transient 
and intermittent nature of parasitemia could lead to 
false-negative results in such cases [30]. 
In the present study, one sample was positive 
by nPCR but negative by cPCR and qPCR. This may 
be due to a possible contamination of this sample. 
The potential PCR carryover associated with 
conventional PCR is usually avoided in real-time PCR, 
since the latter is performed in a closed-tube 
environment [5]. 
Another sample was positive only by qPCR 
but was negative by cPCR and nPCR. This may be 
explained by higher sensitivity of qPCR over other 
PCR assays and its ability to detect very low levels of 
Toxoplasma DNA. Similarly, Li et al. 2004 stated that 
qPCR could detect Toxoplasma B1 gene at a 
concentration as low as 0.05 tachyzoite in a 50-ml 
reaction volume. The use of more than one reaction 
tubes per patient in research might help to avoid 
falsely negative results in Toxoplasma PCR [25]. 
In conclusion, qPCR is a sensitive and 
efficient method for detection of Toxoplasma B1 gene. 
The use of commercial PCR kits offers a good 
alternative to laboratory developed PCR assays being 
standardized and accredited.   
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